Decreased Bioavailability of Rifampin and Other Antituberculosis Drugs in Patients with Advanced Human Immunodeficiency Virus Disease

We evaluated the effects of human immunodeficiency virus (HIV) disease on pharmacokinetics of antituberculosis medications by measuring concentrations of isoniazid and rifampin in blood and of pyrazinamide and ethambutol in urine. Peak concentration and exposure were reduced for rifampin, and rapid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gurumurthy, Prema, Ramachandran, Geetha, Hemanth Kumar, A. K., Rajasekaran, S., Padmapriyadarsini, C., Swaminathan, Soumya, Bhagavathy, S., Venkatesan, P., Sekar, L., Mahilmaran, A., Ravichandran, N., Paramesh, P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2004
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC525439/
https://ncbi.nlm.nih.gov/pubmed/15504887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.11.4473-4475.2004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados